Header2

Evidence Based Dermatology 2nd Edition

ISBN: 978-1-60795-039-4

Maibach
Online content is available to book owners. You must create an account and return to this page.To gain access you will then be asked for your book's keycode.

Price
$250.00

 


January 2012
1138 pages/Hardcover
ISBN: 978-1-60795-039-4
Price: $250.00

Dr. Howard Maibach MD
Professor of Dermatology
UCSF School of Medicine

Farzam Gorouhi, MD,
Research scholar the University of California
School of Medicine, San Francisco
 
Evidence based thinking in clinical medicine has impacted greatly on the physician's approach to clinical care. In addition to promoting the understanding of the evidence based philosophy, the authors have focused on some of the fundamentals in dermatology that need to be approached differently. Issues such as the interpretation of clinical research, disease-oriented evidence versus patient-care evidence, and the use of placebo are examined. This book introduces and encourages the concept of evidence-based patient care in dermatology. This is a growing area in dermatology, and this work presents the ideology and methodology of critical thinking and also the available evidence across the field. Evidence Based Dermatology is aimed at both primary care physicians and dermatologists, encouraging disease management decisions to be based on the highest level of evidence.
 
Evidence Based Dermatology introduces and encourages the concept of evidence-based patient care in dermatology. Authored by over 130 expert contributors from 15 countries, and incorporating a text with all new four color design and images,  this new edition explores disease mechanisms and treatments in greater depth and detail in order to provide more insight for the reader.
 
KEY FEATURES
  • New four color design
  • New four color images
  • Completely revised with many new chapters by Leading Opinion leaders from around the world in Dermatology
  • Online eBook
AUDIENCE
Dermatologists in training and practice
 
 Introduction to Evidence Based Medicine
Part I    
1 Studies and Systematic Reviews on Diagnostic Test Accuracy
2 Diagnostic Accuracy of Teledermatology
3 Evidence-Based Patch Testing
4 Diagnosis of Melanoma
5 Diagnosis of Cutaneous T-Cell Lymphoma
6 Diagnostic Criteria for Cutaneous Lupus Erythematosus
7 Diagnosis of Parasitic Skin Diseases
8 Diagnosis of Hirsutism
    
Part II    
9  Systematic Review and Meta-Analysis
10 Treatment of Hand Dermatitis
11 Treatment of Acute Urticaria and Angioedema
12 Treatment of Chronic Urticaria
13 Atopic Dermatitis
14 Treatment of Melasma
15 Treatment of Psoriasis
16 Treatment of Lichen Planus
17 Treatment of Pemphigus
18 Treatment of Dystrophic Epidermolysis Bullosa
19 Alopecia Areata
20 Treatment of Female Androgenetic Alopecia
21 Treatment of Genital Warts
22 Treatment of Nongenital Warts
23 Treatment of Herpes Simplex
24 Treatment of Herpes Zoster
25 Treatment of Impetigo
26 Treatment of Tinea Capitis
27 Treatment of Tinea Versicolor
28 Treatment of Cutaneous Leishmaniasis
29 Treatment of Head Lice
30 Treatment of Scabies
31 Treatment of Onychomycosis
32 Treatment of Leprosy (Hansen’s Disease)
33 Treatment of Cutaneous Lupus Erythematosus
34 Treatment of Cutaneous Dermatomyositis
35 Treatment of Systemic Sclerosis
36 Treatment of Vitiligo
37 Treatment of Hirsutism (Medical Interventions)
38 Evidence-Based Procedural Dermatology
39 Treatment of Unwanted Hair (Nonmedical Interventions)
40 Tattoo Removal
41 Treatment of Photodamage
42 Chemoprevention of Skin Cancer
43 Treatment of Actinic Keratosis
44 Treatment of Basal Cell Carcinoma
45 Treatment of Cutaneous Squamous Cell Carcinoma
46 Treatment of Cutaneous Melanoma
47 Treatment of Mycosis Fungoides and Sézary Syndrome
48 Treatment of Kaposi’s Sarcoma
49 Treatment of Chronic Wounds
50 Treatment of Venous Leg Ulcers
51 Treatment of Hypertrophic and Keloid Scarring
52 Treatment of Acne (Non-Medical Interventions)
53 Sick Building Syndrome: Cutaneous Manifestations

Part III    
54 Risk Factors for Nonmelanoma Skin Cancer
55 Risk Factors for Alopecia
56 Risk Factors for Occupational Contact Dermatitis
57 Viral Infections and Skin Cancer
    
Part IV    
58 Principles of Pharmacoepidemiology
59 Azathioprine
60 Imiquimod
61 Topical Tar
62 Biologics
63 Topical Immunomodulators
64 Hypnosis
65 Photodynamic Therapy
66 Skin Substitutes
67 Thalidomide
68 Percutaneous Hormone Transfer
    
Part V
69 Cost-effectiveness of Psoriasis Treatments
70 Cost-effectiveness of Rosacea Treatments
71 Cost Effectiveness of Treatment for Non-Melanoma Skin Cancer
    
Part VI    
72 Adherence to Treatment
73 Ethnic Issues in Evidence-Based Dermatology
74 Dermatoepidemiology and Evidence-based Dermatology Training During Residency
75 Electronic Resources For Evidence-Based Dermatology